Daewoong Chemical Takes Over Manufacturing Plant with Finished Product Capability

Published: 2005-03-08 06:56:00

Updated: 2005-03-08 06:56:00

Daewoong Chemical announced last week of its pharmaceutical business extension into the finished product category, by assuming an ownership of Lilly Korea's manufacturing plant with injection, capsule and dry syrup preparation capabilities.

Daewoong Chemical is specialized in the production of pharmaceutical raw materials and intermediates with BGMP (Bulk Good Manufacturing Practice) certifi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.